NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Free Cash Flow Generation Index

Latest as of December 2022: 1.00x

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $29.08 Million represents 1% of operating cash flow ($29.19 Million). Read how much debt does NewAmsterdam Pharma Company N.V. Ordinar carry for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$29.08 Million
USD

Operating Cash Flow

$29.19 Million
USD

Capital Expenditures

$109.43K
USD

NewAmsterdam Pharma Company N.V. Ordinary Shares Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. Explore capital reinvestment ratio of NewAmsterdam Pharma Company N.V. Ordinar to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)

Year-by-year Free Cash Flow Generation Index for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full company profile including market capitalisation, see how much is NewAmsterdam Pharma Company N.V. Ordinar worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.98x $10.44 Million $10.66 Million $221.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).